These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 39094047

  • 1. Extended Chemical and Microbial Stability of Various Hormones in Phytobase and HRT Heavy Cream Bases.
    Taylor S, Haselhorst R.
    Int J Pharm Compd; 2024; 28(4):344-350. PubMed ID: 39094047
    [Abstract] [Full Text] [Related]

  • 2. Compatibility of Various Hormones in Phytobase and HRT Heavy Cream Bases.
    Taylor S, Haselhorst R.
    Int J Pharm Compd; 2024; 28(1):75-81. PubMed ID: 38306623
    [Abstract] [Full Text] [Related]

  • 3. Stability of Fagron's Phytobase Cream Compounded with Various Hormones.
    Wynn T, Taylor S, Zander C.
    Int J Pharm Compd; 2021; 25(2):156-162. PubMed ID: 33798115
    [Abstract] [Full Text] [Related]

  • 4. Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base.
    Polonini HC, Dijkers E, Ferreira AO, Zander C, Taylor S.
    Int J Pharm Compd; 2021; 25(4):336-343. PubMed ID: 34297696
    [Abstract] [Full Text] [Related]

  • 5. Compounded gabapentin for neuropathic pain: Stability and beyond-use date (BUD) in some commonly used bases.
    Shakshuki A, Yeung P, Agu RU.
    J Am Pharm Assoc (2003); 2019; 59(4):514-520. PubMed ID: 30979575
    [Abstract] [Full Text] [Related]

  • 6. Stability Evaluation of Bracketed Diclofenac Sodium USP in VersaPro™ Cream Base, VersaPro™ Gel Base and PLO Gel Mediflo™ 30 Compound Kit.
    Friciu M, Cull E, Haiub H, Lupatini R, Leclair G.
    Int J Pharm Compd; 2024; 28(2):156-160. PubMed ID: 38604143
    [Abstract] [Full Text] [Related]

  • 7. The standardization of nonsterile compounding: a study in quality control and assessment for hormone compounding.
    Wiley TS, Odegard RD, Raden J, Haraldsen JT.
    Int J Pharm Compd; 2014; 18(2):162-8. PubMed ID: 24881121
    [Abstract] [Full Text] [Related]

  • 8. Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase).
    Ip K, Shan A, Yan W, Banov D.
    Int J Pharm Compd; 2018; 22(6):504-511. PubMed ID: 30384351
    [Abstract] [Full Text] [Related]

  • 9. Microbiological Stability of Allopurinol, Clindamycin Hydrochloride, Naltrexone Hydrochloride, Spironolactone and Ursodiol Oral Liquids Compounded in PCCA Base, SuspendIt®.
    Pramar YV.
    Int J Pharm Compd; 2024; 28(4):316-320. PubMed ID: 39094043
    [Abstract] [Full Text] [Related]

  • 10. Bracketed Stability Evaluation of Methimazole USP in PLO Gel Mediflo™30 Pre-Mixed.
    Tran A, Hunt K, Bernal C, Cull E.
    Int J Pharm Compd; 2024; 28(3):182-186. PubMed ID: 38768499
    [Abstract] [Full Text] [Related]

  • 11. Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases.
    Teimouri A, Yeung P, Agu RU.
    Int J Pharm Compd; 2021; 25(4):344-351. PubMed ID: 34297697
    [Abstract] [Full Text] [Related]

  • 12. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K, Neuenschwander PF, Kurdowska AK.
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [Abstract] [Full Text] [Related]

  • 13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 14. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K.
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [Abstract] [Full Text] [Related]

  • 15. Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating.
    Martin M.
    Int J Pharm Compd; 2018 Jan; 22(4):303-312. PubMed ID: 30021186
    [Abstract] [Full Text] [Related]

  • 16. Development and validation of a liquid chromatographic method for the simultaneous determination of estradiol, estriol, estrone, and progesterone in pharmaceutical preparations.
    Wilson P.
    J AOAC Int; 2009 Jan; 92(3):846-54. PubMed ID: 19610377
    [Abstract] [Full Text] [Related]

  • 17. Quality of compounded topical 2% diltiazem hydrochloride formulations for anal fissure.
    Shah M, Sandler L, Rai V, Sharma C, Raghavan L.
    World J Gastroenterol; 2013 Sep 14; 19(34):5645-50. PubMed ID: 24039356
    [Abstract] [Full Text] [Related]

  • 18. Bioidentical hormone therapy: a review of the evidence.
    Cirigliano M.
    J Womens Health (Larchmt); 2007 Jun 14; 16(5):600-31. PubMed ID: 17627398
    [Abstract] [Full Text] [Related]

  • 19. In vitro release, rheological, and stability studies of mefenamic acid coprecipitates in topical formulations.
    Ahmed TA, Ibrahim HM, Ibrahim F, Samy AM, Fetoh E, Nutan MT.
    Pharm Dev Technol; 2011 Oct 14; 16(5):497-510. PubMed ID: 20550465
    [Abstract] [Full Text] [Related]

  • 20. Bioidentical hormones for menopausal therapy.
    Sites CK.
    Womens Health (Lond); 2008 Mar 14; 4(2):163-71. PubMed ID: 19072518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.